Fact CheckerSign in

NCT06209502Completed

Quality-of-Life Index (Q-Index)

Q-Index: A Proof of Concept Investigation Towards Monitoring the Health-related Quality of Life of Parkinson's Disease Patients Using Wearable and Portable Devices.

Source: ClinicalTrials.gov · Last updated 5 Aug 2026

Brief summary (registry, in English)

The main objective of this observational study is to use commonly-used connected objects (smartphones and smartwatches) to remotely assess and monitor the health-related quality of life (HrQoL) of people with Parkinson's disease at different stages of progression.

Status (registry)
Completed
Study type
Observational
Enrollment
95 (actual)
First submitted
8 Jan 2024
Start date
1 Nov 2023
Primary completion date
14 Aug 2025
Lead sponsor
Koios Care
NCT number
NCT06209502

What you commit to

  • Study type: Observational
  • Participants enrolled: 95
  • From 1 Nov 2023 to the primary completion date, 14 Aug 2025
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The candidate suffers from dementia as judged by the investigator. For this we will use MMSE score with a cut-off value ≥ 24.
  • Any Parkinson's disease-related feature or symptom that could interfere with the study conduct and results as assessed by the investigator.

Other

  • The candidate cannot speak or comprehend the French/Dutch (depending on the clinical site s/he belongs to) language at a sufficient level.
  • The reluctance of the candidate or her/his inability to provide written consent (e.g., due to mental health problems or severe physical disabilities).
  • The candidate is not an Android smartphone owner and user for at least six (6) months.
  • The candidate's Android smartphone is not compatible with the Koios Care application.
  • The candidate has exhibited uncontrolled/extreme measures of depression as judged by the expert investigator, e.g., self-harm, suicide attempts or patient admitted to the hospital for a similar reason.
    • \-- If the participant develops such behavior or s/he is admitted to the hospital for the above reasons during the study, then the candidate is immediately removed from the study.

Who the study is looking for

  • Males and females between the ages of 30 and 75
  • Agree to download and install the Koios Care application to their personal Android smartphone.
  • People diagnosed with idiopathic PD based on the MDS-PD criteria. The diagnosis must be confirmed by bradykinesia plus one of the other cardinal signs (resting tremor, rigidity or postural instability not caused by primary visual, vestibular, cerebellar, or proprioceptive dysfunction) being present, without any other known or suspected cause of Parkinson's Disease.
    • o PD patients that are under the effects of a Deep Brain Stimulation (DBS) device or a levodopa pump (duodopa or lecigimon). Given that all other conditions are also met.
  • Score between one-and-a-half (1.5) and three (3) at the H\&Y rating scale in the "ON" state (population A)
  • Score of one (1) at the H\&Y rating scale in the "ON" state (population B)

Age in the registry: 30 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Charleroi, Department of Neurology, EC reference AH/SG-2023-037
Coordinator of this site? Confirm its status
CharleroiBelgiumUnknown status
CHU de Liege, Department of Neurology, EC reference 2023/173
Coordinator of this site? Confirm its status
LiègeBelgiumUnknown status
AZ Oostende, Department of Neurology, EC reference OG-057
Coordinator of this site? Confirm its status
OstendBelgiumUnknown status
AZ Delta, Department of Neurology, EC reference 23045
Coordinator of this site? Confirm its status
RoeselareBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.